Xiidra was eligible for patent challenges on July 11, 2020. By analyzing the patents and regulatory protections it appears that the earliest date for generic entry will be April 15, 2029. This may change due to patent challenges or generic licensing.

Is there a generic drug for Xiidra?

The generic name of Xiidra is lifitegrast; however, no generic versions of Xiidra are currently available. Xiidra is administered twice daily to relieve dryness in the eyes.

When is Restasis going generic?

Allergan will grant Famy Care a license to market a generic version of Restasis in the United States beginning on Feb. 27, 2024, or earlier under certain circumstances.